Coca-Cola Hellenic Bottling Company’s shares were largely unmoved on Tuesday following the release of forecast-matching third-quarter financials. At £21.47 per share, Coca-Cola HBC’s share
U.S. stocks closed higher Tuesday, though the gains were not enough to reverse a three-month losing streak, as investors prepared for major events later
Shares of Sarepta Therapeutics dropped by nearly half on Tuesday amid uncertainty about the future of the company’s $3.2 million gene therapy for Duchenne
Alibaba has upgraded its artificial-intelligence model, the company said Tuesday. Chinese technology firms continue to claim significant advances in AI, despite U.S. efforts to